Overall Score

Growth

Revenue base remains modestly attractive, but earnings power is still weak with TTM net margin at -1.4% and ROE at -3.4%.

Operating efficiency is only slightly positive, with operating ROA at 0.5% and ROIC at 0.5%, limiting long-term compounding potential.

Profitability

Gross margin is healthy at 57.8%, but that has not translated into bottom-line profitability, as EBIT margin is -0.8% and net margin is -1.4%.

Interest coverage is very thin at 0.38x, indicating limited cushion if operating conditions weaken.

Financial Health

Liquidity is acceptable with a current ratio of 1.45x and quick ratio of 1.42x.

Leverage is manageable but meaningful, with net debt to EBITDA at 3.2x and debt to capital at 41.0%.

Valuation

The stock screens as inexpensive on sales and EBITDA, with EV/Sales at 1.0x and EV/EBITDA at 11.4x.

However, the valuation is less compelling on cash flow, with price to free cash flow at 42.4x and free cash flow yield only 2.4%.

Momentum

No recent news was provided to indicate a material change in business momentum.

The current profile still reflects a mixed setup: stable liquidity and reasonable valuation, but weak profitability and limited growth compounding.